SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX (SPCX) is facing intense market scrutiny as investors brace for a massive lockup expiration that will allow insiders and employees to begin selling millions of shares. While some community members anticipate a sharp decline due to this significant supply increase, others view the current volatility as a strategic buying opportunity and speculate that major institutional players may have already priced in the event.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending significantly after crushing earnings expectations with record revenue growth and a raised full-year outlook, fueling speculation of a major short squeeze due to high short interest. Investors and the trading community are closely watching the stock as it gains momentum, with many debating the potential for a sustained breakout following this strong fundamental catalyst.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to the official closing of its acquisition of SkyWater Technology and a series of high-profile government contract awards, including from DARPA and the NRO. Investors are actively debating the company's valuation, the long-term strategic benefits of vertical integration via the new foundry, and the potential for a surge in bookings as the firm positions itself as a key player in national security.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Investors are closely tracking the potential Senate vote on the Clarity Act as a critical catalyst for institutional adoption, with community sentiment split between frustration over price stagnation and long-term optimism regarding the asset's underlying utility. Many are debating whether Ripple's infrastructure and real-world payment use cases will eventually decouple the token from broader market volatility and regulatory uncertainty.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending due to a combination of an executive whistleblower lawsuit alleging customs violations and the market bracing for an upcoming earnings report. The community is actively debating the credibility of management following these allegations and the recent firing of the company's Chief Revenue Officer, while long-term investors remain focused on whether upcoming drone delivery and defense contract updates will finally drive sustained value.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is facing heightened market volatility following an earnings report that missed expectations due to project delays and margin compression, sparking intense debate among investors about the company's ability to execute on its record backlog. While bears point to structural profitability concerns and competitive pressures, bulls are actively loading up on shares, highlighting the company's critical role in the AI data center infrastructure buildout as a primary long-term catalyst.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing heightened investor activity and volatility as the market evaluates the potential of its DMD franchise, including the upcoming expansion of Elevidys and critical readouts for its pipeline assets. The community is intensely debating the long-term outlook for the company's DMD business versus its research pipeline under new leadership, while many remain focused on whether upcoming data readouts and profitability trends will finally break the stock out of its recent trading range.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is gaining momentum as investors eye a valuation rebalance following record Q2 revenue and a substantial backlog growth. The community is actively discussing the stock's potential for a short squeeze, driven by high short interest and anticipation that strong performance in space infrastructure will trigger a move toward higher price targets.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares experienced a sharp decline following mixed second-quarter results that fell short of elevated market expectations for revenue and guidance, despite ongoing growth in its AI-driven advertising business. While some investors are concerned about decelerating growth and profit margins, many community members are dismissing the sell-off as a temporary overreaction, pointing to strong share buybacks and the recent conclusion of an SEC inquiry as reasons to favor a rebound.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is currently the focus of intense community speculation and volatility as investors react to the company's upcoming earnings report and news of major institutional portfolio shifts. While some market participants are optimistic about growth heading into football season and the expansion of prediction markets, others are vocal about concerns regarding increased sector competition and the stock's recent price performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals (RYTM) delivered earnings and revenue surprises of +9.88% and +6.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for

Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Rhythm Pharmaceuticals (RYTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm PR Newswire NEW YORK, July 21, 2026 NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

Is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Poised for Growth After Encouraging Setmelanotide Trial Results?

Is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Poised for Growth After Encouraging Setmelanotide Trial Results...

Strength Seen in Acadia (ACAD): Can Its 6.8% Jump Turn into More Strength?

Acadia (ACAD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Rhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 Results

Rhythm Pharmaceuticals (NASDAQ: RYTM) reported better-than-expected earnings, with strong demand for IMCIVREE and potential launches in Europe and Japan.read more...

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $137.00 at Royal Bank Of Canada

Royal Bank Of Canada increased their price objective on shares of Rhythm Pharmaceuticals from $136.00 to $137.00 and gave the company an "outperform" rating in a research report on Wednesday...

Wells Fargo & Company Boosts Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $144.00

Wells Fargo & Company boosted their price target on Rhythm Pharmaceuticals from $143.00 to $144.00 and gave the stock an "overweight" rating in a research note on Wednesday...

Why Rhythm Pharmaceuticals Stock Triumphed on Tuesday

Key PointsThe biotech was in the headlines recently after the FDA approved a new indication for its single commercialized drug...

$RYTM Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.73 up 2.67% YoY
• Reported revenue of $71.25M up 46.91% YoY
• For the year ending December 31, 2026, Rhythm Pharmaceuticals anticipates approximately $363 million to $397 million in Non-GAAP Operating Expenses, which excludes stock-based compensation and fixed consideration related to in-licensing.

Stocktwits

Rhythm Pharmaceuticals Inc.

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.73 up 2.67% YoY
• Reported revenue of $71.25M up 46.91% YoY
• For the year ending December 31, 2026, Rhythm Pharmaceuticals anticipates approximately $363 million to $397 million in Non-GAAP Operating Expenses, which excludes stock-based compensation and fixed consideration related to in-licensing.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

RYTM Stock Jumps 4% On Imcivree Revenue Growth: Firm Awaits Approval In Acquired Hypothalamic Obesity By March

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$110.71
Prev Close	$105.78
Open	$110.83
Dividend Yield	0.00%
50-Day Moving Average	$100.98
Beta	0.98
Avg. Volume	644,325.04
PE Ratio	-35.28

52-Week High	$122.20
52-Week Low	$74.50
Market Capitalization	$7.26B
EPS (Annual)	-$3.11
Price to Book	61.65
Revenue Per Employee	$458,350.24

Feed

News

Sentiment

Earnings

Fundamentals

Info